<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Serum C-<z:chebi fb="7" ids="16670">peptide</z:chebi> can be used in Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> as a measure of endogenous insulin secretion, but practicalities of collection limit its routine clinical use </plain></SENT>
<SENT sid="1" pm="."><plain>Urine C-<z:chebi fb="7" ids="16670">peptide</z:chebi> <z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio is a non-invasive alternative that is stable for at least 3 days at room temperature in <z:chebi fb="1" ids="33118">boric acid</z:chebi> preservative </plain></SENT>
<SENT sid="2" pm="."><plain>We aimed to assess the utility of urine C-<z:chebi fb="7" ids="16670">peptide</z:chebi> <z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio in individuals with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> as an alternative to serum C-<z:chebi fb="7" ids="16670">peptide</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We assessed, in 77 individuals with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, the reproducibility of, and correlations between, fasting and postprandial urine C-<z:chebi fb="7" ids="16670">peptide</z:chebi> <z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio and serum C-<z:chebi fb="7" ids="16670">peptide</z:chebi>, and the impact of <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e> (estimated glomerular filtration rate &lt; 60 ml min(-1) 1.73 m(-2)) on these correlations </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Urine C-<z:chebi fb="7" ids="16670">peptide</z:chebi> <z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio was at least as reproducible as serum C-<z:chebi fb="7" ids="16670">peptide</z:chebi> [fasting coefficient of variation mean (95% CI): 28 (21-35)% vs. 38 (26-59)% and 2-h post-meal 26 (18-33)% vs. 27 (20-34)% </plain></SENT>
<SENT sid="5" pm="."><plain>Urine C-<z:chebi fb="7" ids="16670">peptide</z:chebi> <z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio 2 h post-meal was correlated with stimulated serum C-<z:chebi fb="7" ids="16670">peptide</z:chebi>, both the 2-h value (r = 0.64, P &lt; 0.001) and the 2-h area under the C-<z:chebi fb="7" ids="16670">peptide</z:chebi> curve (r = 0.63, P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>The association seen was similar in patients with and without moderate <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e> (P = 0.6) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: In patients with Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, a single urine C-<z:chebi fb="7" ids="16670">peptide</z:chebi> <z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio is a stable, reproducible measure that is well correlated with serum C-<z:chebi fb="7" ids="16670">peptide</z:chebi> following meal stimulation, even if there is moderate <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Urine C-<z:chebi fb="7" ids="16670">peptide</z:chebi> <z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio therefore has potential for use in clinical practice in the assessment of Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>